Comment
doi: 10.1016/j.eururo.2018.08.011.
Epub 2018 Aug 28.
Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
Affiliations
- PMID: 30170873
- DOI: 10.1016/j.eururo.2018.08.011
Item in Clipboard
Comment
Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
Eur Urol.
2018 Dec.
No abstract available
Comment in
-
Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell Carcinoma.Eur Urol. 2019 Mar;75(3):e64-e66. doi: 10.1016/j.eururo.2018.10.031. Epub 2018 Nov 1. Eur Urol. 2019. PMID: 30391082 No abstract available.
Comment on
-
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Clinical Trial.
Similar articles
-
Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma.Eur Urol. 2019 May;75(5):876-877. doi: 10.1016/j.eururo.2019.02.018. Epub 2019 Feb 28. Eur Urol. 2019. PMID: 30826222 No abstract available.
-
Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417-27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma?Eur Urol Oncol. 2019 May;2(3):340-341. doi: 10.1016/j.euo.2018.08.002. Epub 2018 Aug 24. Eur Urol Oncol. 2019. PMID: 31200852 No abstract available.
-
Has the Age of Cytoreductive Nephrectomy Come to an End?: Commentary on: Sunitinib Alone or After Nephrectomy in Metastatic Renal-Cell Carcinoma.Urology. 2018 Nov;121:1-2. doi: 10.1016/j.urology.2018.07.007. Epub 2018 Aug 2. Urology. 2018. PMID: 30077538 No abstract available.
-
Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift?Bull Cancer. 2018 Dec;105 Suppl 3:S229-S234. doi: 10.1016/S0007-4551(18)30377-1. Bull Cancer. 2018. PMID: 30595151
-
Adjuvant therapy after nephrectomy for renal cell carcinoma.Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:33-36. doi: 10.1111/ajco.13056. Asia Pac J Clin Oncol. 2018. PMID: 30489037 Review.
Cited by
-
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma.J Oncol. 2019 Apr 1;2019:7309205. doi: 10.1155/2019/7309205. eCollection 2019. J Oncol. 2019. PMID: 31057615 Free PMC article. Review.
-
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma.Cureus. 2019 Mar 13;11(3):e4244. doi: 10.7759/cureus.4244. Cureus. 2019. PMID: 31131167 Free PMC article.
-
Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database.Front Surg. 2021 Aug 30;8:716455. doi: 10.3389/fsurg.2021.716455. eCollection 2021. Front Surg. 2021. PMID: 34557516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
